Loading...
Loading...
DERM| Name | Value |
|---|---|
| Revenues | 16.0M |
| Cost of Revenue | 7.7M |
| Gross Profit | 8.2M |
| Operating Expense | 18.2M |
| Operating I/L | -10.0M |
| Other Income/Expense | -0.6M |
| Interest Income | 0.1M |
| Pretax | -10.6M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -10.6M |
Journey Medical Corporation is a pharmaceutical company specializing in the development and commercialization of dermatological products in the United States. The company's portfolio includes Qbrexza, Accutane, Targadox, Ximino, and Exelderm, addressing conditions such as hyperhidrosis and severe acne. Additionally, it sells doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution. By marketing these products, Journey Medical Corporation generates revenue from the sale of medicated cloth towelettes, oral isotretinoin drugs, and other dermatological treatments, catering to the needs of patients with various skin conditions.
